Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 21, 2015; 21(47): 13240-13249
Published online Dec 21, 2015. doi: 10.3748/wjg.v21.i47.13240
Published online Dec 21, 2015. doi: 10.3748/wjg.v21.i47.13240
Figure 1 Histidine decarboxylase (A) and vesicular monoamine transporter 2 (B) immunostained type I enterochromaffin-like cell neuroendocrine tumour (consecutive sections).
Only a few scattered histidine decarboxylase (HDC)-immunoreactive cells are present in the tumour, whereas virtually all neoplastic cells display VMAT-2 immunoreactivity. Bars = 50 μm (A, B).
- Citation: Tsolakis AV, Grimelius L, Granerus G, Stridsberg M, Falkmer SE, Janson ET. Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours. World J Gastroenterol 2015; 21(47): 13240-13249
- URL: https://www.wjgnet.com/1007-9327/full/v21/i47/13240.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i47.13240